ASPIRIN PROLONGS BLEEDING-TIME IN UREMIA BY A MECHANISM DISTINCT FROM PLATELET CYCLOOXYGENASE INHIBITION

被引:79
作者
GASPARI, F
VIGANO, G
ORISIO, S
BONATI, M
LIVIO, M
REMUZZI, G
机构
[1] MARIO NEGRI INST PHARMACOL RES,VIA GAVAZZENI 11,I-24100 BERGAMO,ITALY
[2] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY
[3] OSPED RIUNITI BERGAMO,I-24100 BERGAMO,ITALY
关键词
D O I
10.1172/JCI113020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:1788 / 1797
页数:10
相关论文
共 30 条
[1]  
ANDREASEN F, 1973, ACTA PHARMACOL TOX, V32, P417
[2]  
CUTLER RE, 1983, TXB NEPHROLOGY
[3]   PHARMACOLOGY OF PLATELET INHIBITION IN HUMANS - IMPLICATIONS OF THE SALICYLATE-ASPIRIN INTERACTION [J].
DEGAETANO, G ;
CERLETTI, C ;
DEJANA, E ;
LATINI, R .
CIRCULATION, 1985, 72 (06) :1185-1193
[4]   ETHANOL POTENTIATION OF ASPIRIN-INDUCED PROLONGATION OF THE BLEEDING-TIME [J].
DEYKIN, D ;
JANSON, P ;
MCMAHON, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (14) :852-854
[5]   UREMIC BLEEDING [J].
DEYKIN, D ;
MADIAS, NE ;
MILLER, KB ;
HARRINGTON, JT ;
KASSIRER, JP ;
MCCAULEY, J ;
LEVEY, A ;
STROM, J .
KIDNEY INTERNATIONAL, 1983, 24 (05) :698-705
[8]  
GASPARI F, IN PRESS THER DRUG M
[9]  
GIBALDI M, 1975, PHARMACOKINETICS
[10]   PREVENTION OF THROMBOSIS IN PATIENTS ON HEMODIALYSIS BY LOW-DOSE ASPIRIN [J].
HARTER, HR ;
BURCH, JW ;
MAJERUS, PW ;
STANFORD, N ;
DELMEZ, JA ;
ANDERSON, CB ;
WEERTS, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (11) :577-579